How do I install the Ata Lt4 Overreplacement Fracture skill?

Run npx skillmds@latest add dromlakhani/ata-lt4-overreplacement-fracture in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Ata Lt4 Overreplacement Fracture safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Ata Lt4 Overreplacement Fracture?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Ata Lt4 Overreplacement Fracture free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Ata Lt4 Overreplacement Fracture?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Ata Lt4 Overreplacement Fracture by dromlakhani

Name: Ata Lt4 Overreplacement Fracture
Rating: 4.2 (5 reviews)
Author: dromlakhani

Ata Lt4 Overreplacement Fracture

Monitors levothyroxine (L-T4) replacement in hypopituitarism to prevent over-replacement and associated fracture risk. Triggered when managing L-T4 therapy, especially when levothyroxine dose adjustment is needed to avoid overdose.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Monitor levothyroxine replacement to avoid over-replacement fracture risk

STEP 1 — Gather Information

Collect current L-T4 dose, serum free T4 (fT4), TSH (note: unreliable in central hypothyroidism), symptoms of over- or under-replacement (e.g., palpitations, weight loss, fatigue), age, sex, estrogen status (pregnancy, oral contraceptives), comorbidities, and baseline bone health if available.

STEP 2 — Rule In / Rule Out

Is the patient’s fT4 above the mid-to-upper half of the laboratory reference range? If yes, rule in over-replacement; if no, rule out over-replacement and consider assessing for under-replacement or maintaining current dose.

STEP 3 — Classify or Stratify

Classify degree of over-replacement: mild (fT4 slightly above mid-upper half), moderate (fT4 clearly above upper half), or marked (fT4 significantly above reference range).

STEP 4 — Decide

For mild over-replacement, reduce L-T4 dose by 12.5–25 µg; for moderate/marked, reduce by 25–50 µg. Recheck fT4 in 6–8 weeks and adjust further as needed to keep fT4 within mid-to-upper half of reference range.

Clinical Guardrails / Mimics / Pitfalls

Do not rely on TSH alone to guide L-T4 dosing in central hypothyroidism; avoid using TSH to adjust therapy. Consider age-related dose reductions, estrogen-induced increases in thyroid-binding globulin (requiring higher L-T4 doses in pregnancy or oral estrogen therapy), and comorbidities that alter clearance. Avoid abrupt dose changes; taper gradually. Monitor for signs of hyperthyroidism (tremor, insomnia, tachycardia) and bone health, especially in postmenopausal women.

Concrete Clinical Example

A 58-year-old postmenopausal woman on L-T4 100 µg daily presents for routine follow-up. Her fT4 is at the upper limit of the reference range (upper half). Clinician reduces dose to 87.5 µg daily and rechecks fT4 in 6 weeks, finding it now within the mid-to-upper half, maintaining the dose.

Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118

---name: ata-lt4-overreplacement-fracturedescription: Monitors levothyroxine (L-T4) replacement in hypopituitarism to prevent over-replacement and associated fracture risk. Triggered when managing L-T4 therapy, especially when levothyroxine dose adjustment is needed to avoid overdose.---# Monitor levothyroxine replacement to avoid over-replacement fracture risk## STEP 1 — Gather InformationCollect current L-T4 dose, serum free T4 (fT4), TSH (note: unreliable in central hypothyroidism), symptoms of over- or under-replacement (e.g., palpitations, weight loss, fatigue), age, sex, estrogen status (pregnancy, oral contraceptives), comorbidities, and baseline bone health if available.## STEP 2 — Rule In / Rule OutIs the patient’s fT4 above the mid-to-upper half of the laboratory reference range? If yes, rule in over-replacement; if no, rule out over-replacement and consider assessing for under-replacement or maintaining current dose.## STEP 3 — Classify or StratifyClassify degree of over-replacement: mild (fT4 slightly above mid-upper half), moderate (fT4 clearly above upper half), or marked (fT4 significantly above reference range).## STEP 4 — DecideFor mild over-replacement, reduce L-T4 dose by 12.5–25 µg; for moderate/marked, reduce by 25–50 µg. Recheck fT4 in 6–8 weeks and adjust further as needed to keep fT4 within mid-to-upper half of reference range.## Clinical Guardrails / Mimics / PitfallsDo not rely on TSH alone to guide L-T4 dosing in central hypothyroidism; avoid using TSH to adjust therapy. Consider age-related dose reductions, estrogen-induced increases in thyroid-binding globulin (requiring higher L-T4 doses in pregnancy or oral estrogen therapy), and comorbidities that alter clearance. Avoid abrupt dose changes; taper gradually. Monitor for signs of hyperthyroidism (tremor, insomnia, tachycardia) and bone health, especially in postmenopausal women.## Concrete Clinical ExampleA 58-year-old postmenopausal woman on L-T4 100 µg daily presents for routine follow-up. Her fT4 is at the upper limit of the reference range (upper half). Clinician reduces dose to 87.5 µg daily and rechecks fT4 in 6 weeks, finding it now within the mid-to-upper half, maintaining the dose.**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118

Frequently asked questions